Walleye Trading
GH icon

Walleye Trading’s Guardant Health GH Stock Holding History

Walleye Trading’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.52M Sell
70,600
-71,300
-50% -$7.16M 0.01% 993
2025
Q4 		$14.5M Sell
141,900
-32,100
-18% -$2.87M 0.02% 749
2025
Q3 		$10.9M Buy
174,000
+128,100
+279% +$6.97M 0.02% 854
2025
Q2 		$2.39M Buy
45,900
+36,000
+364% +$1.61M ﹤0.01% 1628
2025
Q1 		$422K Buy
9,900
+3,800
+62% +$164K ﹤0.01% 2629
2024
Q4 		$186K Buy
6,100
+4,900
+408% +$138K ﹤0.01% 3269
2024
Q3 		$27.5K Sell
1,200
-5,000
-81% -$142K ﹤0.01% 3626
2024
Q2 		$179K Buy
+6,200
New +$144K ﹤0.01% 3149
2024
Q1 		– Sell
-7,900
Closed -$214K – 4980
2023
Q4 		$214K Sell
7,900
-800
-9% -$21K ﹤0.01% 3736
2023
Q3 		$258K Sell
8,700
-3,700
-30% -$130K ﹤0.01% 3447
2023
Q2 		$444K Sell
12,400
-156,800
-93% -$4.5M ﹤0.01% 2843
2023
Q1 		$3.97M Buy
169,200
+140,000
+479% +$4M 0.01% 1203
2022
Q4 		$794K Sell
29,200
-23,900
-45% -$1.09M ﹤0.01% 2426
2022
Q3 		$2.86M Sell
53,100
-88,800
-63% -$4.56M 0.01% 1426
2022
Q2 		$5.72M Buy
141,900
+122,300
+624% +$6.06M 0.02% 937
2022
Q1 		$1.3M Sell
19,600
-16,500
-46% -$1.13M ﹤0.01% 2007
2021
Q4 		$3.61M Buy
36,100
+1,600
+5% +$165K 0.01% 1189
2021
Q3 		$4.31M Sell
34,500
-4,900
-12% -$582K 0.02% 1019
2021
Q2 		$4.89M Sell
39,400
-16,500
-30% -$2.22M 0.02% 807
2021
Q1 		$8.53M Buy
55,900
+42,400
+314% +$6.41M 0.04% 393
2020
Q4 		$1.74M Sell
13,500
-13,600
-50% -$1.56M 0.01% 1492
2020
Q3 		$3.03M Buy
27,100
+17,100
+171% +$1.56M 0.02% 859
2020
Q2 		$811K Buy
10,000
+5,100
+104% +$411K 0.01% 1851
2020
Q1 		$341K Sell
4,900
-32,000
-87% -$2.46M ﹤0.01% 2187
2019
Q4 		$2.88M Buy
36,900
+30,300
+459% +$2.18M 0.02% 938
2019
Q3 		$421K Buy
6,600
+700
+12% +$61.7K ﹤0.01% 2306
2019
Q2 		$509K Buy
+5,900
New +$451K ﹤0.01% 2174

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Trading's GH Position: Q1 2025 in Review

Walleye Trading sold out of Guardant Health (GH) in Q1 2025, closing a stake of 1,600 shares — an estimated $69K sold.

Walleye Trading first reported a position in GH in Q2 2020 and held it in 11 quarters. The position peaked at $2.72M in Q1 2021. 341 funds tracked by Wall St. Rank hold GH as of Q1 2025.

  • Walleye Trading reported no remaining Guardant Health position as of Q1 2025 after selling out during the quarter.
  • Walleye Trading sold 1,600 Guardant Health shares in Q1 2025, an estimated $69K.
  • Walleye Trading first reported a position in Guardant Health in Q2 2020 and held it in 11 quarters.
  • Walleye Trading's Guardant Health position peaked at $2.72M in Q1 2021.
  • 341 funds tracked by Wall St. Rank held Guardant Health as of Q1 2025.

Based on Walleye Trading's 13F filing for Q1 2025, filed 14 May 2025.